Search Results 81-90 of 3457 for Solid
Participants with advanced or metastatic solid tumors for which no standard therapy is available will be enrolled in Part 1. In Part 1, the primary ...
... solid tumor malignancies, excluding gastrointestinal tumors and tumors that have originated or metastasized to the liver for which no standard treatment ...
Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors · Overview · Participation eligibility · Participating Mayo Clinic locations · More ...
A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors · Overview · Participation eligibility · Participating Mayo Clinic locations · More ...
The purpose of this study is to assess the safety and tolerability of TJ011133 in participants with solid tumors and lymphoma. Participation eligibility.
... solid tumor types, including but not limited to cholangiocarcinoma, chondrosarcoma, and glioma. Participation eligibility. Participant eligibility includes ...
The purpose of this study is to evaluate the safety and tolerability of LYL797, a ROR1-targeted CAR T-cell therapy, in patients with ROR1+ relapsed or ...
About this study. The purpose of this study is to evaluate the safety and anti-tumor activity of LYL845, an epigenetically reprogrammed tumor infiltrating ...
A Dose Escalation Study of HFB301001 in Adult Patients with Advanced Solid Tumors · Overview · Participation eligibility · Participating Mayo Clinic locations.
Curriculum. Two residents in the Solid Organ Transplant Residency at Mayo Clinic in Arizona look at a. Clinical training.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.